GRACE

cancergrace.org

 

GRACE
Avatar

EGFRm+ NSCLC: Should We Treat With Durvalumab?

By GRACE FEATURING Jack West, Jarushka Naidoo, Gilberto Lopes
By GRACE FEATURING Jack West, Jarushka Naidoo, Gilberto Lopes
14 views
September 6, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss
ASCO Lung Review 2022
14:26

The Need for Molecular Testing to Identify Targets in mNSCLC

GRACE

J. West, J. Naidoo, G. Lopes

110 views
12:38

IO Alone vs. IO + Chemo for NSCLC Pts w/PD-L1≥50%

GRACE

J. West, J. Naidoo, G. Lopes

266 views
07:22

Chemo/IO vs. IO vs. Chemo for KRAS-Mutated NSCLC

GRACE

J. West, J. Naidoo, G. Lopes

404 views
07:37

Pembrolizumab/Ramucirumab vs. Standard 2L Treatment After Chemo and …

GRACE

J. West, J. Naidoo, G. Lopes

402 views
09:17

Amivantamab/Lazertinib for EGFRm+ NSCLC Acquired Resistance

GRACE

J. West, J. Naidoo, G. Lopes

33 views
07:11

EGFRm+ NSCLC: Should We Treat With Durvalumab?

GRACE

J. West, J. Naidoo, G. Lopes

14 views
05:29

Patritumab Deruxtecan: Use in Previously Treated NSCLC Without Mutat…

GRACE

J. West, J. Naidoo, G. Lopes

24 views
04:28

SKYSCRAPER-2 Trial: Anti-“TIGIT” IO + Chemo/IO for ES-SCLC

GRACE

J. West, J. Naidoo, G. Lopes

195 views
07:56

CheckMate 816: Combining Chemo and Opdivo in Stage 1B-3A NSCLC

GRACE

J. West, J. Naidoo, G. Lopes

546 views
12:08

Adagrasib for Previously Treated KRAS G12C+ NSCLC

GRACE

J. West, J. Naidoo, G. Lopes

36 views